NCT04112446View on ClinicalTrials.gov

Study to Evaluate Absorption, Metabolism and Excretion of Single-dose [14C]-Saroglitazar in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 20, 2019

Primary Completion Date

October 29, 2019

Study Completion Date

October 29, 2019

Conditions

Healthy

Interventions

DRUG

Saroglitazar magnesium

On Day 1, subjects will receive a single oral dose of \[14C\]-saroglitazar magnesium

Trial Locations (1)

53704

Covance Clinical Research Unit Inc., Madison

All Listed Sponsors

lead

Zydus Therapeutics Inc.

INDUSTRY

NCT04112446 - Study to Evaluate Absorption, Metabolism and Excretion of Single-dose [14C]-Saroglitazar in Healthy Male Subjects | Biotech Hunter | Biotech Hunter